1996
DOI: 10.1159/000333969
|View full text |Cite
|
Sign up to set email alerts
|

The Uniform Approach to Breast Fine Needle Aspiration Biopsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

1997
1997
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(5 citation statements)
references
References 58 publications
0
5
0
Order By: Relevance
“…The IAC YRSB uses terminology essentially identical to a previously published system for breast cytology proposed following a meeting in Bethesda, MD, USA [20-22]. This “Bethesda System” proposed the use of 5 categories (benign, atypical/indeterminate, suspicious/probably malignant, malignant, and unsatisfactory).…”
Section: Discussionmentioning
confidence: 99%
“…The IAC YRSB uses terminology essentially identical to a previously published system for breast cytology proposed following a meeting in Bethesda, MD, USA [20-22]. This “Bethesda System” proposed the use of 5 categories (benign, atypical/indeterminate, suspicious/probably malignant, malignant, and unsatisfactory).…”
Section: Discussionmentioning
confidence: 99%
“…[6] There have been studies to delineate the distinctive cytologic features of benign and malignant papillary lesions of the breast. [23] It has been suggested from these and other studies that malignant papillary lesions have high cellularity, complex branching papillary fragments, single intact atypical cells, absence of bland columnar cells and lack of foamy or hemosiderin-laden macrophages in the background.…”
Section: Discussionmentioning
confidence: 99%
“…The inclusion criteria were: (i) all the clinically suspected and preoperative fine-needle aspiration cytology (FNAC) confirmed[3] patients (Category 5) of breast carcinoma who had undergone mastectomy in the Department of Surgery and (ii) patients who gave the consent and fully cooperated during the study procedure. The exclusion criteria were: (i) breast carcinoma patients not confirmed by cytology (other than Category 5) and/or (ii) patients having a history of preoperative chemotherapy or radiotherapy for breast carcinoma.…”
Section: Methodsmentioning
confidence: 99%
“…[12] The National Cancer Institute (NCI), Bethesda, sponsored conference had also recommended that the tumor grading on FNA (fine needle aspiration) material should be incorporated in FNA reports for prognostication. [3]…”
Section: Introductionmentioning
confidence: 99%